Nicolás Roche

Instituto de Salud Carlos III (ES)

Research Areas

Discover Papers by Nicolás Roche

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

Publications

1198

Citations

39684

i10-index

396

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Global Strategy for the Diagnosis, Management, and...	2017	3119
Impaired type I interferon activity and inflammato...	2020	3078
2022 ESC/ERS Guidelines for the diagnosis and trea...	2022	3015
Global Strategy for the Diagnosis, Management, and...	2019	1872
Global Initiative for Chronic Obstructive Lung Dis...	2023	1023
Global Strategy for the Diagnosis, Management, and...	2017	856
Indacaterol–Glycopyrronium versus Salmeterol–Fluti...	2016	841
Global Strategy for the Diagnosis, Management and ...	2017	682
Global Initiative for Chronic Obstructive Lung Dis...	2023	653
Global Strategy for the Diagnosis, Management, and...	2017	630

Publications

1.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Year: 2017Citations: 3119DOI: 10.1164/rccm.201701-0218pp
2.
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Year: 2020Citations: 3078DOI: 10.1126/science.abc6027
3.
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Year: 2022Citations: 3015DOI: 10.1093/eurheartj/ehac237
4.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Year: 2019Citations: 1872DOI: 10.1183/13993003.00164-2019
5.
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Year: 2023Citations: 1023DOI: 10.1183/13993003.00239-2023
6.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Year: 2017Citations: 856DOI: 10.1183/13993003.00214-2017
7.
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Year: 2016Citations: 841DOI: 10.1056/nejmoa1516385
8.
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report
Year: 2017Citations: 682DOI: 10.1111/resp.13012
9.
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Year: 2023Citations: 653DOI: 10.1164/rccm.202301-0106pp
10.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Year: 2017Citations: 630DOI: 10.1016/j.arbr.2017.02.001

About Nicolás Roche

Nicolás Roche is a researcher with 1198 publications and 39684 citations. They are affiliated with Instituto de Salud Carlos III. Their research focuses on . With an h-index of 87, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Nicolás Roche and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year